FAREVA will use TraceLink serialization solutions for FMD compliance

TraceLink announced that FAREVA has selected TraceLink's serialization solutions to ensure compliance with the EU Falsified Medicines Directive (FMD).

Ajinomoto Althea and OmniChem formed Ajinomoto Bio-Pharma Services

Ajinomoto Althea and OmniChem are integrating their businesses and operations as a unified CDMO, and changing their name to Ajinomoto Bio-Pharma Services.

Piramal Pharma Solutions launches Xcelerate platform

research tube
Piramal Pharma Solutions (PPS), a global leader in Contract Development and Manufacturing Solutions, announced the launch of its Xcelerate Integrated Solutions™ platform.

Almac Group strengthens its position in the CDMO market

Almac Group, the global contract development and manufacturing organisation, announced its global analytical services capabilities spanning UK, Europe and USA.

Idifarma announced renewal of its EU-GMP certificate

Idifarma, a Spanish contract development and manufacturing organisation (CDMO), announced the installation of GEA Niro Mobile Minor equipment in a new dedicated area in its EU GMP plant.

Recipharm receives EMVO approval

Recipharm, a leading contract development and manufacturing organisation has received European Medicines Verification Organisation (EMVO) approval to submit serialisation data to the European Hub.

Avara obtains sterile manufacturing facility from Sandoz

Avara Pharmaceutical Services announced that it has closed on the transaction with Sandoz to acquire the largest sterile manufacturing facility for injectable medicines in Canada.

AMRI signed collaboration agreement with Metrion Biosciences

AMRI and Metrion Biosciences Limited, the specialist ion channel CRO and drug discovery company, announced they have signed a new collaboration agreement.

AGC will boost its GMP-compliant pharma production

AGC announced a major expansion of facilities at its Chiba Plant that will result in an increase in the company’s GMP-compliant synthetic pharmaceutical intermediate and active ingredient production capacity.

Novacap acquires PCI Synthesis CDMO

Novacap announced that it has signed an agreement to acquire Boston-based PCI Synthesis, a leading U.S. pharmaceutical contract development and manufacturing organization (CDMO).

Stelis Biopharma and Oncobiologics start a new CDMO

Marketed under the name, Bio2Source, Oncobiologics and Stelis Biopharma will offer development stage biotech companies access to a suite of CDMO services.

Global CDMO Recipharm makes its preparations for Brexit

Recipharm, the contract development and manufacturing organisation (CDMO), has established a dedicated taskforce to manage the potential impact of Brexit on its organisation.

Avara buys the largest sterile manufacturing facility in Canada

Avara Pharmaceutical Services, a world-class contract development and manufacturing organization acquires the largest sterile manufacturing facility for injectable medicines in Canada from a leading global pharmaceutical company.

Recipharm and Hadasit started a partnership

Recipharm, the contract development and manufacturing organisation (CDMO), has partnered with Hadasit Medical Research Services and Development to offer combined clinical, biological and chemical services.

Ardena boosts its API manufacturing capabilities by acquiring Syntagon

Contract development and manufacturing organisation (CDMO) Ardena has acquired Syntagon, a leading contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients.

Avid Bioservices will expand and optimize its capabilities

Avid Bioservices, a dedicated contract development and manufacturing organization, published an update on the company's ongoing efforts to expand and optimize its process development capabilities and laboratory space.